Socias, Joyzelle Jane .

HRN: 27-31-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFUROXIME 1.5GM (VIAL)
06/11/2025
06/12/2025
IV
1.5g
Q8
Pelvic Lap
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines